No price history available for this symbol yet.
Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Sector
Medical - Devices
Shenzhen New Industries Biomedical Engineering Co., Ltd., engages in the research, development, production, and sale of clinical laboratory instruments and in vitro diagnostic reagents to hospitals in China and internationally. It offers immunoassay machine, biochemistry/electrolyte, integrated system, lab automation, molecular diagnostics, hemolumi and rapid test solutions. The company was founded in 1995 and is based in Shenzhen, China.
www.snibe.comNo one on the platform currently holds 300832.SZ.
No tracked institution reports a position in 300832.SZ as of their last filing.
No one on the platform has traded 300832.SZ yet.
Consensus-seeded revenue, margins, and exit multiples. This is a scenario tool, not investment advice.
Consensus does not cover every selected forecast year. Later assumptions are extrapolated from available analyst estimates.
| Metric | Historical average | My assumptions | ||||
|---|---|---|---|---|---|---|
| 1 year | 5 years | 10 years | Low | Mid | High | |
| ROIC % | 20.2% | 22.3% | 43.8% | — | — | — |
| Rev. Growth % | 0.9% | 15.8% | ||||
| Profit Margin % | 35.4% | 39.9% | 43.5% | |||
| Free Cash Flow Margin % | 27.1% | 22.1% | 28.1% | |||
| Exit P/E | — | — | — | |||
| Exit P/FCF | — | — | — | |||
| Desired Annual Return % | — | — | — | |||
At today's price, your expected annual return is — on the P/E track.
At today's price, your expected annual return is — on the P/E track.
At today's price, your expected annual return is — on the P/E track.
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
| Year | Est. revenue | Growth | Est. EPS | EPS range | Fwd P/E | # Analysts |
|---|---|---|---|---|---|---|
| 2026 | $5.1B | +10.4% | $2.35 | $2.28–$2.42 | — | 6 |
| 2027 | $5.9B | +14.4% | $2.75 | $2.54–$2.91 | — | 5 |
| 2028 | $6.7B | +13.5% | $3.19 | $2.89–$3.63 | — | 8 |
Forward consensus · growth is YoY vs the prior fiscal-year estimate · Fwd P/E at the current price · source: Financial Modeling Prep
Beat consensus in 1 of the last 8 reported quarters
| Reported | Est. EPS | Actual | Surprise |
|---|---|---|---|
| 2026-08-13 | $0.52 | $0.54 | +2.3% |
| 2026-04-27 | $0.57 | $0.53 | -6.5% |
| 2026-04-27 | $0.57 | $0.53 | -6.4% |
| 2025-10-28 | $0.55 | $0.55 | -0.2% |
| 2025-08-25 | $0.56 | $0.42 | -25.6% |
| 2025-04-25 | $0.58 | $0.56 | -4.3% |
| 2025-04-25 | $0.63 | $0.57 | -8.9% |
| 2024-10-28 | $0.70 | $0.61 | -12.9% |
| Symbol | Price | Today | Mkt cap | P/E |
|---|---|---|---|---|
| 300832.SZShenzhen New Industries Biomedical Engineering Co., Ltd. | $48.95 | +0.84% | $38.5B | — |
| 000999.SZChina Resources Sanjiu Medical & Pharmaceutical Co., Ltd. | $24.12 | -0.74% | $40.1B | — |
| 002252.SZShanghai RAAS Blood Products Co., Ltd. | $4.91 | -0.81% | $32.4B | — |
| 002422.SZSichuan Kelun Pharmaceutical Co., Ltd. Class A | $40.65 | -1.76% | $64.7B | — |
| 300347.SZHangzhou Tigermed Consulting Co., Ltd |
| $55.81 |
| -1.05% |
| $41.2B |
| — |
| 300759.SZPharmaron Beijing Co., Ltd. | $42.36 | -0.68% | $62.6B | — |
| 300896.SZImeik Technology Development Co.,Ltd. | $88.34 | -0.11% | $26.7B | — |
Source: Financial Modeling Prep · peers by sector/industry